| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
Answers - Mortgage
A mortgage is a means of securing charge on a property of other immovable assets usually for the purpose of financing its purchase. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product The word mortgage derives from the French words mort meaning dead, and gage meaning pledge. The implication was that the property ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in was dead or useless for the borrower if he could not repay the loan. In most countries it is common to fund both residential and co lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. mmercial properties by creating a mortgage. The primary parties in creating a mortgage are the lender and the borrower. The lender here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is also known as the creditor or the mortgage, the one to whom the property is mortgaged. Similarly the borrower is also known as d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro the debtor or the mortgagor, the one who mortgages the property. Because of the high stakes and the complex legal issues involved b ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc oth parties are usually represented by solicitors. A mortgage usually creates a lien or right to the title of the property. It doe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi not transfer absolute ownership to the lender. A mortgage is created by an instrument known as mortgage deed. Despite having a lie nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n on the property, the lender has to take recourse to law to recover his funds if the debtor defaults on the payments. A legal proc and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ess declaring that the debt is due and that the borrower has defaulted in the payments is required before the property can be sold. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Mortgage lenders are banks or financial institutions that lend funds to borrowers for the specific purchase of land and property, ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a and secure the loans by way of a mortgage on the land or property created in their favor. The borrower needs funds to purchase the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod land or property. He expects to pay back the loan along with interest by utilizing the assets in his business or from some other e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin xpected income. Mortgage lenders have funds available but are unable to leverage the funds to produce high returns. Hence both bene tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen it from the transaction. Mortgage lenders need protection from the eventuality that the borrower will default in his commitments. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Towards this end they get the assets mortgaged in their favor. The mortgage is created by a legal charge, through which the ownersh ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ip of the assets remain with the borrower, but the mortgage lenders have the right to take possession of and even sell the assets. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products This is known as foreclosure. Mortgage lenders are further protected by the recording of the charge in a public register. This reg . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de istration makes it easier for them to foreclose the assets should the need arise. This registration serves another purpose as well. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Before lending the funds, mortgage lenders carry out a search of the registers to ensure that the assets are not already mortgaged tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Do Others Say About Your Meetings? Top Tips for Growing YOUR E-Mail Marketing List
|